Formoterol versus short‐acting beta‐agonists as relief medication for adults and children with asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Formoterol Versus Short‐acting Beta‐agonists as Relief Medication for Adults and Children With Asthma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434751/all/images/repview. Accessed 13 June 2024.
Formoterol versus short‐acting beta‐agonists as relief medication for adults and children with asthma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434751/all/images/repview. Accessed June 13, 2024.
Formoterol versus short‐acting beta‐agonists as relief medication for adults and children with asthma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434751/all/images/repview
Formoterol Versus Short‐acting Beta‐agonists as Relief Medication for Adults and Children With Asthma [Internet]. In: Cochrane Abstracts. [cited 2024 June 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434751/all/images/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Formoterol versus short‐acting beta‐agonists as relief medication for adults and children with asthma
ID - 434751
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434751/all/images/repview
DB - Evidence Central
DP - Unbound Medicine
ER -